Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individual Patient Compassionate Use of GX-I7

NCT04289155 is registered in ClinicalTrials.gov with Genexine, Inc. as lead sponsor.

NCT NCT04289155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04289155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individual Patient Compassionate Use of GX-I7
Lead sponsor
Genexine, Inc.
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, glioblastoma, high grade glioma, melanoma, recurrent glioblastoma